Levofloxacin 500 mg once daily versus cefuroxime 250 mg twice daily in patients with acute exacerbations of chronic obstructive bronchitis: clinical efficacy and exacerbation-free interval (Q42621079)
Jump to navigation
Jump to search
scientific article published on 18 May 2007
Language | Label | Description | Also known as |
---|---|---|---|
English | Levofloxacin 500 mg once daily versus cefuroxime 250 mg twice daily in patients with acute exacerbations of chronic obstructive bronchitis: clinical efficacy and exacerbation-free interval |
scientific article published on 18 May 2007 |
Statements
1 reference
Levofloxacin 500 mg once daily versus cefuroxime 250 mg twice daily in patients with acute exacerbations of chronic obstructive bronchitis: clinical efficacy and exacerbation-free interval (English)
1 reference
Patrick Petitpretz
1 reference
Claudie Choné
1 reference
François Trémolières
1 reference
Investigator Study Group
1 reference
18 May 2007
1 reference
1 reference
Identifiers
1 reference